These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18233965)

  • 21. [Initiation modes of spontaneous monomorphic ventricular tachycardia in patients with Chagas heart disease].
    Abello M; González-Zuelgaray J; López C; Labadet C
    Rev Esp Cardiol; 2008 May; 61(5):487-93. PubMed ID: 18462652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
    Wilkoff BL; Ousdigian KT; Sterns LD; Wang ZJ; Wilson RD; Morgan JM;
    J Am Coll Cardiol; 2006 Jul; 48(2):330-9. PubMed ID: 16843184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ventricular tachycardias based on time and frequency domain analyses of cycle length variability in patients with implantable cardioverter defibrillator.
    Sierra G; Molin F; Savard P; Soucy B; Nadeau R
    Can J Cardiol; 1999 Nov; 15(11):1223-8. PubMed ID: 10579736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
    Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premature ventricular complexes as a trigger for ventricular fibrillation.
    Sánchez Muñoz JJ; García-Alberola A; Martínez-Sánchez J; Peñafiel-Verdú P; Caro-Martínez C; Manzano-Fernández S; Valdés Chávarri M
    Rev Esp Cardiol; 2010 Jul; 63(7):798-801. PubMed ID: 20609313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of stored implanted cardiac defibrillator electrograms in catheter ablation of ventricular fibrillation.
    Lowery CM; Tzou WS; Aleong RG; Nguyen DT; Varosy PD; Katz DF; Heath RR; Schuller JL; Lewkowiez L; Sauer WH
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):76-85. PubMed ID: 23078144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast and slow torsade de pointes--electrocardiographic characteristics.
    Kukla P; Słowiak-Lewińska T; Szczuka K; Plato A; Bromblik A; Hajduk B; Kluczewski M; Przewor M
    Kardiol Pol; 2004 Apr; 60(4):342-7. PubMed ID: 15226783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cycle length variability during ventricular fibrillation: a novel predictor of arrhythmia recurrence.
    Yokoshiki H; Kohya T; Sato M; Sasaki K; Yotsukura A; Sakurai M; Kitabatake A
    J Electrocardiol; 2003 Apr; 36(2):137-46. PubMed ID: 12764696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure and heart rate immediately after termination of short-term ventricular fibrillation.
    Schipke JD; Heusch G; Fritzsche A; Meyer K; Gams E; Winter J
    Resuscitation; 2008 Dec; 79(3):404-9. PubMed ID: 18952352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract.
    Noda T; Shimizu W; Taguchi A; Aiba T; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2005 Oct; 46(7):1288-94. PubMed ID: 16198845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical usefulness of stored electrograms in implantable defibrillators].
    Madrid AH; Moro Serrano C; Luis Mestre J; Lozano I; Megías MA
    Rev Esp Cardiol; 1996 Mar; 49(3):204-13. PubMed ID: 8685524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian, daily, and seasonal distributions of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Anand K; Aryana A; Cloutier D; Hee T; Esterbrooks D; Mooss AN; Mohiuddin SM
    Am J Cardiol; 2007 Oct; 100(7):1134-8. PubMed ID: 17884377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ventricular fibrillation in implantable defibrillators with automatic gain control amplifiers: effects of programming sensitivity.
    Schulte B; Sperzel J; Schwarz T; Pitschner HF; Strupp G; Neuzner J
    Europace; 2000 Apr; 2(2):160-2. PubMed ID: 11225942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.